Related Experiment Video
Updated: Jan 6, 2026
Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
Clinical Profile and Predictors of Repeated Relapse in Type 1 Autoimmune Pancreatitis: A Multicenter Observational
Sho Saeki1,2, Yasutaka Ishii1, Keiji Hanada3
1Department of Gastroenterology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.
Background And Aim:
Type 1 autoimmune pancreatitis (AIP) is a form of pancreatitis that responds well to glucocorticoid therapy and often results in clinical and radiological remission. However, AIP frequently relapses during long-term follow-up. While initial relapse is well described, repeated relapses are poorly understood. This study aimed to clarify their clinical features and predictors.
Methods:
We retrospectively analyzed 270 patients diagnosed with type 1 AIP between 2004 and 2022 across 12 institutions. Clinical characteristics were compared among the non-relapse, single-relapse, and multiple-relapse groups. Predictors of a second relapse were assessed in patients who experienced at least one relapse using Kaplan-Meier and Cox regression analyses.
Results:
During a median follow-up of 65 months, 107 patients (40%) experienced at least one relapse, and 32 (12%) had multiple relapses. The median time to second relapse was 49 months, and the cumulative second relapse rate reached 47.4% at 7 years. Multivariable analysis identified extra-pancreatic sclerosing cholangitis at first relapse as an independent predictor of a second relapse (hazard ratio, 2.773; 95% confidence interval, 1.294-5.941; p = 0.009). Furthermore, 61% of patients whose first relapse involved the extra-pancreatic bile duct experienced multiple relapses, often at the same site, and 73% of them were still on glucocorticoid therapy at the second relapse.
Conclusions:
Second and subsequent relapses are common in type 1 AIP, and are particularly likely when the first relapse involves extra-pancreatic sclerosing cholangitis. These patients may require more intensive monitoring and treatment beyond glucocorticoid monotherapy.
Related Concept Videos
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:27Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...